Francesco Di Mario, Pellegrino Crafa, Lorella Franzoni, Antonio Tursi, Giovanni Brandimarte, Michele Russo, Kryssia Isabel Rodriguez-Castro, Marilisa Franceschi, Nicola De Bortoli, Edoardo Savarino
BACKGROUND: Proton pump inhibitors (PPIs) are currently the reference drugs for gastroesophageal reflux disease (GERD), but symptoms often recur after their withdrawal. Moreover, whether prokinetics or barrier drugs used alongside PPIs are more effective remains under debate. OBJECTIVES: The aim of the study was to assess the efficacy of different therapeutic approaches to GERD treatment. MATERIAL AND METHODS: We enrolled 211 grade A reflux esophagitis patients who consented to participate in this non-randomized, open-label trial...
September 4, 2023: Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University